Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006

Henry Krum; Michael V. Jelinek; Simon Stewart; Andrew Sindone; John J. Atherton; Anna L. Hawkes; John Amerena; John Beltrame; Louise Burrell; Duncan Campbell; Patricia Davidson; Carmine DePasquale; Rob Doughty; Donald Esmore; Michael Feneley; Andrew Galbraith; Richard Gilbert; Alan Goble; David Hare; John Horowitz; John Kalman; David Kaye; Ann Keogh; Robert Larbalestier; James Leitch; Peter McDonald; Tom Marwick; Mark McGuire; Deborah Meyers; Phil Mottram; Carol Pollock; Warren Walsh

doi:10.5694/j.1326-5377.2006.tb00690.x

Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006

Henry Krum, Michael V. Jelinek, Simon Stewart, Andrew Sindone, John J. Atherton, Anna L. Hawkes, John Amerena, John Beltrame, Louise Burrell, Duncan Campbell, Patricia Davidson, Carmine DePasquale, Rob Doughty, Donald Esmore, Michael Feneley, Andrew Galbraith, Richard Gilbert, Alan Goble, David Hare, John HorowitzJohn Kalman, David Kaye, Ann Keogh, Robert Larbalestier, James Leitch, Peter McDonald, Tom Marwick, Mark McGuire, Deborah Meyers, Phil Mottram, Carol Pollock, Warren Walsh

Research output: Contribution to journal › Article › peer-review

119 Scopus citations

Abstract

• Chronic heart failure (CHF) is found in 1.5/6-2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged, ≥65 years. • CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70 years). • Common causes of CHF are ischaemic heart disease (present in > 50% of new cases), hypertension (about two-thirds of cases) and idiopathic dilated cardiomyopathy (around 5%-10% of cases). • Diagnosis is based on clinical features, chest x-ray and objective measurement of ventricular function (eg, echocardiography). Plasma levels of B-type natriuretic peptide (BNP) may have a role in diagnosis, primarily as a test for exclusion. Diagnosis may be strengthened by a beneficial clinical response to treatment(s) directed towards amelioration of symptoms. • Management involves prevention, early detection, amelioration of disease progression, relief of symptoms, minimisation of exacerbations, and prolongation of survival.

Original language	English (US)
Pages (from-to)	549-556
Number of pages	8
Journal	Medical Journal of Australia
Volume	185
Issue number	10
DOIs	https://doi.org/10.5694/j.1326-5377.2006.tb00690.x
State	Published - Nov 20 2006
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.5694/j.1326-5377.2006.tb00690.x

Cite this

Krum, H., Jelinek, M. V., Stewart, S., Sindone, A., Atherton, J. J., Hawkes, A. L., Amerena, J., Beltrame, J., Burrell, L., Campbell, D., Davidson, P., DePasquale, C., Doughty, R., Esmore, D., Feneley, M., Galbraith, A., Gilbert, R., Goble, A., Hare, D., ... Walsh, W. (2006). Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Medical Journal of Australia, 185(10), 549-556. https://doi.org/10.5694/j.1326-5377.2006.tb00690.x

Krum, H, Jelinek, MV, Stewart, S, Sindone, A, Atherton, JJ, Hawkes, AL, Amerena, J, Beltrame, J, Burrell, L, Campbell, D, Davidson, P, DePasquale, C, Doughty, R, Esmore, D, Feneley, M, Galbraith, A, Gilbert, R, Goble, A, Hare, D, Horowitz, J, Kalman, J, Kaye, D, Keogh, A, Larbalestier, R, Leitch, J, McDonald, P, Marwick, T, McGuire, M, Meyers, D, Mottram, P, Pollock, C & Walsh, W 2006, 'Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006', Medical Journal of Australia, vol. 185, no. 10, pp. 549-556. https://doi.org/10.5694/j.1326-5377.2006.tb00690.x

@article{a900ee50a7304c1a9df6b9415750838f,

title = "Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006",

abstract = "• Chronic heart failure (CHF) is found in 1.5/6-2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged, ≥65 years. • CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70 years). • Common causes of CHF are ischaemic heart disease (present in > 50% of new cases), hypertension (about two-thirds of cases) and idiopathic dilated cardiomyopathy (around 5%-10% of cases). • Diagnosis is based on clinical features, chest x-ray and objective measurement of ventricular function (eg, echocardiography). Plasma levels of B-type natriuretic peptide (BNP) may have a role in diagnosis, primarily as a test for exclusion. Diagnosis may be strengthened by a beneficial clinical response to treatment(s) directed towards amelioration of symptoms. • Management involves prevention, early detection, amelioration of disease progression, relief of symptoms, minimisation of exacerbations, and prolongation of survival.",

author = "Henry Krum and Jelinek, {Michael V.} and Simon Stewart and Andrew Sindone and Atherton, {John J.} and Hawkes, {Anna L.} and John Amerena and John Beltrame and Louise Burrell and Duncan Campbell and Patricia Davidson and Carmine DePasquale and Rob Doughty and Donald Esmore and Michael Feneley and Andrew Galbraith and Richard Gilbert and Alan Goble and David Hare and John Horowitz and John Kalman and David Kaye and Ann Keogh and Robert Larbalestier and James Leitch and Peter McDonald and Tom Marwick and Mark McGuire and Deborah Meyers and Phil Mottram and Carol Pollock and Warren Walsh",

year = "2006",

month = nov,

day = "20",

doi = "10.5694/j.1326-5377.2006.tb00690.x",

language = "English (US)",

volume = "185",

pages = "549--556",

journal = "Medical Journal of Australia",

issn = "0025-729X",

publisher = "Australasian Medical Publishing Co. Ltd",

number = "10",

}

TY - JOUR

T1 - Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006

AU - Krum, Henry

AU - Jelinek, Michael V.

AU - Stewart, Simon

AU - Sindone, Andrew

AU - Atherton, John J.

AU - Hawkes, Anna L.

AU - Amerena, John

AU - Beltrame, John

AU - Burrell, Louise

AU - Campbell, Duncan

AU - Davidson, Patricia

AU - DePasquale, Carmine

AU - Doughty, Rob

AU - Esmore, Donald

AU - Feneley, Michael

AU - Galbraith, Andrew

AU - Gilbert, Richard

AU - Goble, Alan

AU - Hare, David

AU - Horowitz, John

AU - Kalman, John

AU - Kaye, David

AU - Keogh, Ann

AU - Larbalestier, Robert

AU - Leitch, James

AU - McDonald, Peter

AU - Marwick, Tom

AU - McGuire, Mark

AU - Meyers, Deborah

AU - Mottram, Phil

AU - Pollock, Carol

AU - Walsh, Warren

PY - 2006/11/20

Y1 - 2006/11/20

N2 - • Chronic heart failure (CHF) is found in 1.5/6-2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged, ≥65 years. • CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70 years). • Common causes of CHF are ischaemic heart disease (present in > 50% of new cases), hypertension (about two-thirds of cases) and idiopathic dilated cardiomyopathy (around 5%-10% of cases). • Diagnosis is based on clinical features, chest x-ray and objective measurement of ventricular function (eg, echocardiography). Plasma levels of B-type natriuretic peptide (BNP) may have a role in diagnosis, primarily as a test for exclusion. Diagnosis may be strengthened by a beneficial clinical response to treatment(s) directed towards amelioration of symptoms. • Management involves prevention, early detection, amelioration of disease progression, relief of symptoms, minimisation of exacerbations, and prolongation of survival.

AB - • Chronic heart failure (CHF) is found in 1.5/6-2.0% of Australians. Considered rare in people aged less than 45 years, its prevalence increases to over 10% in people aged, ≥65 years. • CHF is one of the most common reasons for hospital admission and general practitioner consultation in the elderly (≥ 70 years). • Common causes of CHF are ischaemic heart disease (present in > 50% of new cases), hypertension (about two-thirds of cases) and idiopathic dilated cardiomyopathy (around 5%-10% of cases). • Diagnosis is based on clinical features, chest x-ray and objective measurement of ventricular function (eg, echocardiography). Plasma levels of B-type natriuretic peptide (BNP) may have a role in diagnosis, primarily as a test for exclusion. Diagnosis may be strengthened by a beneficial clinical response to treatment(s) directed towards amelioration of symptoms. • Management involves prevention, early detection, amelioration of disease progression, relief of symptoms, minimisation of exacerbations, and prolongation of survival.

UR - http://www.scopus.com/inward/record.url?scp=33751416414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751416414&partnerID=8YFLogxK

U2 - 10.5694/j.1326-5377.2006.tb00690.x

DO - 10.5694/j.1326-5377.2006.tb00690.x

M3 - Article

C2 - 17115967

AN - SCOPUS:33751416414

SN - 0025-729X

VL - 185

SP - 549

EP - 556

JO - Medical Journal of Australia

JF - Medical Journal of Australia

IS - 10

ER -

Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this